NCT04083222View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

July 20, 2020

Study Completion Date

July 20, 2020

Conditions
Hypertension
Interventions
DRUG

Placebo

ISIS 757456-matching placebo solution administered as SC injection.

DRUG

ISIS 757456

ISIS 757456 administered as SC injection.

Trial Locations (9)

23510

York Clinical Research LLC, Norfolk

32127

Progressive Medical Research, Port Orange

33434

Excel Medical Clinical Trials, Boca Raton

35209

Central Alabama Research, Birmingham

44124

Ohio Clinical Research - Lyndhurst, Lyndhurst

46260

Midwest Institute for Clinical Research, Indianapolis

77040

Juno Research, LLC, Houston

90057

National Research Institute - Wilshire, Los Angeles

92780

Orange County Research Center, Tustin

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY